The book delves into advancements in personalized medicine, highlighting the transition from generalized treatments to tailored strategies through AI and machine learning. It first emphasizes the role of biomarkers in training predictive models and neural networks, enhancing disease diagnosis and patient management.
[...]
It then explores AI-driven healthcare systems, particularly the use of microservices to improve scalability and management. Additionally, it examines regulatory challenges, the need for AI explainability, and the PINXEL framework, which defines explainability requirements using the technology acceptance model (TAM) and the diffusion of innovation theory (DOI). (Estratto dal sito dell' editore)
